The Clinical and Research team at SAGA Diagnostics specializes in developing and validating ultrasensitive liquid biopsy tests for cancer diagnosis and monitoring at variant frequencies as low as 0.001%. They drive clinical development, oversee laboratory and quality assurance, conduct cutting-edge research, and employ advanced bioinformatics to ensure accurate and reliable results.
View all